Nrf2-mediated amelioration of nonalcoholic steatohepatitis and liver fibrosis involves downregulation of lipogenic genes, induction of antioxidant genes, and suppression of both oxidative and endoplasmic reticulum stress. Here, NFE2L2 is linked to metabolic dysfunction-associated steatohepatitis.